Irinotecan Response (UGT1A1)

See Cepmed’s Personalized Medicine Portal for more information about this test

Read More

Select your province to learn about access to testing & services in your area.

Overview

Irinotecan (Camptosar®) is a chemotherapeutic drug used for treating metastatic and recurrent colorectal cancer. Some individuals are more sensitive to this drug and at high risk of toxicity. Genetic testing can aid in identifying people with a high risk of toxicity who may require a lower than normal dose. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Providers

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Irinotecan (Camptosar®) is a chemotherapeutic drug used for treating metastatic and recurrent colorectal cancer. Some individuals are more sensitive to this drug and at high risk of toxicity. Genetic testing can aid in identifying people with a high risk of toxicity who may require a lower than normal dose. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Providers

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Irinotecan (Camptosar®) is a chemotherapeutic drug used for treating metastatic and recurrent colorectal cancer. Some individuals are more sensitive to this drug and at high risk of toxicity. Genetic testing can aid in identifying people with a high risk of toxicity who may require a lower than normal dose. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Providers

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Irinotecan (Camptosar®) is a chemotherapeutic drug used for treating metastatic and recurrent colorectal cancer. Some individuals are more sensitive to this drug and at high risk of toxicity. Genetic testing can aid in identifying people with a high risk of toxicity who may require a lower than normal dose. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Providers

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Irinotecan (Camptosar®) is a chemotherapeutic drug used for treating metastatic and recurrent colorectal cancer. Some individuals are more sensitive to this drug and at high risk of toxicity. Genetic testing can aid in identifying people with a high risk of toxicity who may require a lower than normal dose. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Providers

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Irinotecan (Camptosar®) is a chemotherapeutic drug used for treating metastatic and recurrent colorectal cancer. Some individuals are more sensitive to this drug and at high risk of toxicity. Genetic testing can aid in identifying people with a high risk of toxicity who may require a lower than normal dose. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Providers

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Irinotecan (Camptosar®) is a chemotherapeutic drug used for treating metastatic and recurrent colorectal cancer. Some individuals are more sensitive to this drug and at high risk of toxicity. Genetic testing can aid in identifying people with a high risk of toxicity who may require a lower than normal dose. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Providers

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Irinotecan (Camptosar®) is a chemotherapeutic drug used for treating metastatic and recurrent colorectal cancer. Some individuals are more sensitive to this drug and at high risk of toxicity. Genetic testing can aid in identifying people with a high risk of toxicity who may require a lower than normal dose. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Providers

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Irinotecan (Camptosar®) is a chemotherapeutic drug used for treating metastatic and recurrent colorectal cancer. Some individuals are more sensitive to this drug and at high risk of toxicity. Genetic testing can aid in identifying people with a high risk of toxicity who may require a lower than normal dose. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Providers

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Irinotecan (Camptosar®) is a chemotherapeutic drug used for treating metastatic and recurrent colorectal cancer. Some individuals are more sensitive to this drug and at high risk of toxicity. Genetic testing can aid in identifying people with a high risk of toxicity who may require a lower than normal dose. Follow the Read More button above to learn more.

Currently, this type of genetic testing is not readily available in Canada. Discuss this test with your physician to see if it could be beneficial for you.

Public Providers

Resources

Private Providers

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program